Predictors of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) failure: analysis of comorbidities and complications – a 10-year experience

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00098892%3A_____%2F25%3A10159700" target="_blank" >RIV/00098892:_____/25:10159700 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61988987:17110/25:A2603DN3

Výsledek na webu

<a href="https://www.termedia.pl/Predictors-of-veno-arterial-extracorporeal-membrane-oxygenation-VA-ECMO-failure-analysis-of-comorbidities-and-complications-a-10-year-experience,40,57310,0,1.html" target="_blank" >https://www.termedia.pl/Predictors-of-veno-arterial-extracorporeal-membrane-oxygenation-VA-ECMO-failure-analysis-of-comorbidities-and-complications-a-10-year-experience,40,57310,0,1.html</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5114/kitp.2025.158037" target="_blank" >10.5114/kitp.2025.158037</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Predictors of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) failure: analysis of comorbidities and complications – a 10-year experience

Popis výsledku v původním jazyce

Introduction: Extracorporeal membrane oxygenation (ECMO) is a rescue method in the treatment of severe cardiac and/or respiratory failure in patients with different etiological factors of this failure and also of different ages. The question of ECMO support of patients has arisen more frequently recently, as a result of the expansion of the indication criteria for this support and the increase in the contingent of patients with severe cardiac and/or respiratory failure. Material and methods: A retrospective study was performed in patients with veno-arterial ECMO (VA-ECMO) support for cardiac or cardiorespiratory failure over a 10-year period at a single ECMO center. In this study, comorbidities and peri- and post-procedural complications were analyzed in search of predictors of failure of the method. Furthermore, the composition of treated patients was analyzed according to the indication for support and known comorbidities at the time the support was indicated. Results: The largest indication group among patients supported by VA-ECMO was those with acute coronary syndrome (n = 42), accounting for nearly 37% of the cohort. Only 22 patients in the entire cohort had no comorbidities, accounting for 19%. Complications occurred in 77 patients, accounting for nearly 68% of patients supported. Conclusions: Analysis of the results shows a correlation of survival with the incidence of infection at the cannulation site and limb ischemia. Survival at 30 days correlated with multiorgan dysfunction syndrome, cerebral edema and cannulation site infection. Survival at 90 days correlated with cannulation site infection. Survival at 12 months correlated with limb ischemia and cannulation site infection. Of the comorbidities known at the time of indication, only atrial fibrillation was correlated with 12-month survival and hospitalization mortality (significance level p = 0.049).

Název v anglickém jazyce

Predictors of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) failure: analysis of comorbidities and complications – a 10-year experience

Popis výsledku anglicky

Introduction: Extracorporeal membrane oxygenation (ECMO) is a rescue method in the treatment of severe cardiac and/or respiratory failure in patients with different etiological factors of this failure and also of different ages. The question of ECMO support of patients has arisen more frequently recently, as a result of the expansion of the indication criteria for this support and the increase in the contingent of patients with severe cardiac and/or respiratory failure. Material and methods: A retrospective study was performed in patients with veno-arterial ECMO (VA-ECMO) support for cardiac or cardiorespiratory failure over a 10-year period at a single ECMO center. In this study, comorbidities and peri- and post-procedural complications were analyzed in search of predictors of failure of the method. Furthermore, the composition of treated patients was analyzed according to the indication for support and known comorbidities at the time the support was indicated. Results: The largest indication group among patients supported by VA-ECMO was those with acute coronary syndrome (n = 42), accounting for nearly 37% of the cohort. Only 22 patients in the entire cohort had no comorbidities, accounting for 19%. Complications occurred in 77 patients, accounting for nearly 68% of patients supported. Conclusions: Analysis of the results shows a correlation of survival with the incidence of infection at the cannulation site and limb ischemia. Survival at 30 days correlated with multiorgan dysfunction syndrome, cerebral edema and cannulation site infection. Survival at 90 days correlated with cannulation site infection. Survival at 12 months correlated with limb ischemia and cannulation site infection. Of the comorbidities known at the time of indication, only atrial fibrillation was correlated with 12-month survival and hospitalization mortality (significance level p = 0.049).

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30212 - Surgery

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Kardiochirurgia i Torakochirurgia Polska

ISSN

1731-5530

e-ISSN

1897-4252

Svazek periodika

22

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

PL - Polská republika

Počet stran výsledku

6

Strana od-do

271-276

Kód UT WoS článku

001655817300005

EID výsledku v databázi Scopus

2-s2.0-105028125826